A Phase 1/2 Study of TAS3351 in NSCLC Patients With EGFRmt

Terminated Phase 1 NCT05765734

Study Description

A Study to Investigate the Safety and Effectiveness of TAS3351 in Non-Small Cell Lung Cancer Patients With a Specific Gene Mutation

Study Details

Registry ID:: NCT05765734
Conditions:: Non-Small Cell Lung Cancer
Phase:: Phase 1
Target Enrollment:: 18 participants
Start Date:: May 25, 2023
Age Range:: 18–999 years
Healthy Volunteers:: No

Study Locations (32 sites)

Shizuoka Cancer Center
Sunto-gun, ShizuokaJapan, Japan
Hospital Universitario 12 de Octubre
MadridSpain, Spain
Hospital Universitari Vall d'Hebron
BarcelonaSpain, Spain
Hospital Universitari Vall d'Hebron
BarcelonaSpain, Spain
IEO Istituto Europeo di Oncologia
MilanoItaly, Italy
IEO Istituto Europeo di Oncologia
MilanoItaly, Italy
Institut Gustave Roussy
Villejuif cedex, Val De MarneFrance, France
Institut Gustave Roussy
Villejuif cedexFrance, France
Universitaetsklinikum Koeln
Cologne, North Rhine-WestphaliaGermany, Germany
Universitaetsklinikum Koeln
Koeln, Nordrhein WestfalenGermany, Germany
Universitaetsklinikum Koeln
KoelnGermany, Germany
Leiden University Medical Center (LUMC)
LeidenNetherlands, Netherlands
Leiden University Medical Center (LUMC)
LeidenNetherlands, Netherlands
Antoni van Leeuwenhoek
AmsterdamNetherlands, Netherlands
Antoni van Leeuwenhoek
AmsterdamNetherlands, Netherlands
The Christie Hospital
ManchesterUnited Kingdom, United Kingdom
Georgetown University - Lombardi Comprehensive Cancer Center
Washington, District of ColumbiaUnited States, United States
Next Oncology - Virginia
Fairfax, VirginiaUnited States, United States
Tennessee Oncology
Nashville, TennesseeUnited States, United States
University of Texas M. D. Anderson Cancer Center
Houston, TexasUnited States, United States
Seoul National University Hospital
SeoulKorea, Democratic People's Republic of, Korea, Democratic People's Republic of
Asan Medical Center
SeulKorea, Republic of, Korea, Republic of
Seoul National University Hospital
SeoulKorea, Republic of, Korea, Republic of
Inje University Haeundae Paik Hospital
BusanKorea, Republic of, Korea, Republic of
Shizuoka Cancer Center
Sunto-gunJapan, Japan
Shizuoka Cancer Center
Sunto-gunJapan, Japan
Shizuoka Cancer Center
Sunto-gun, Shizuoka-KenJapan, Japan
Cancer Institute Hospital of JFCR
Koto-KuJapan, Japan
Cancer Institute Hospital of JFCR
Koto-KuJapan, Japan
National Cancer Center Hospital East
Kashiwa-shiJapan, Japan
National Cancer Center Hospital East
Kashiwa-shiJapan, Japan
National Cancer Center Hospital East
Kashiwa-shi, Chiba-KenJapan, Japan

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →